“★【아시아365.COM / 가입코드GK】 팔로우가입 땅콩검증 파티가입 파티주소 파티먹튀 파티검증★”的搜索结果，显示 281-290 项，共有 12651 项

1. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   Rochester, Minn. The aims of this study are to investigate the presence of tumor cells after filtration of autologous blood products by intraoperative cell ...

2. 妇产科- 临床试验- 妙佑医疗国际

   A Registry to Follow Long-Term Outcomes for Mother and Child Pairs After Fetal Surgery for Spina Bifida. Rochester, Minn. The purpose of this study is to ...

3. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   Rochester, Minn. The purpose of this study is to determine if a new drug combination, pirtobrutinib and venetoclax, will help Chronic Lymphocytic Leukemia (CLL) ...

4. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   This partially randomized clinical trial studies cholecalciferol in improving survival in patients with newly diagnosed cancer with vitamin D insufficiency.

5. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   ... follow-up therapy. Patients in cohorts 1.11 and 1.12 (currently lacking detectable cancer) will undergo the collection at least 4 weeks after conclusion of ...

6. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   Rochester, Minn. 99mTc-MIP-1404 is a radioactive diagnostic imaging agent indicated for imaging men with newly diagnosed prostate cancer whose biopsy indicates ...

7. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   Rochester, Minn. The purpose of this study is to determine if a new drug combination, pirtobrutinib and venetoclax, will help Chronic Lymphocytic Leukemia (CLL) ...

8. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   Rochester, Minn. This phase III trial compares the effect of vinorelbine with vincristine, dactinomycin, and cyclophosphamide (VAC) followed by vinorelbine and ...

9. 广告与赞助政策- 妙佑医疗国际

   我们拒绝任何被认为有悖于我们使命的广告。我们的网站或刊物中出现的广告并不意味着对广告公司或产品的认可。广告商和赞助商不得做出未经证实的健康声明，也不得做出妙佑 ...

10. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

    ... follow-up to identify those who developed breast cancer (cases) and those who did not (controls); the application of potential biomarkers of risk to this ...